Nanotrope is an early stage, privately held company developing engineered nanoparticles for drug delivery and other biomedical applications. Nanotrope was founded in 2004 to commercialize nanoscale droplet technology being developed at the University of California, Irvine. The droplet technology provides high-precision, digital control of biochemical processes at the nanoscale.
